Biohaven Ltd (BHVN) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Biohaven Ltd   (NYSE: BHVN)


Biohaven Ltd's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Biohaven Ltd's ROI in the second quarter of 2026?
Biohaven Ltd recorded a cumulative net loss of $-587 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -173.36%.

Within the Healthcare sector 720 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 4220, from total ROI ranking in the first quarter of 2026 at 4950.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -12.08 % -4.44 % -14.26 % -4.78 % 1.7 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 308 414 336 296 426
Return On Investment (TTM) -173.36 % -176 % -218.49 % -211.13 % -199.2 %
BHVN's Overall Ranking # 4220 # 4950 # 4364 # 4407 # 4504
Seq. Investment Change TTM -8.02 % 8.83 % -8.48 % -4.03 % -0.02 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -587 -648 -739 -780 -767




Return On Investment BHVN's Ranking
Within: No.
Industry # 338
Sector # 721
Overall # 4220

Return On Investment Statistics
High Average Low
-68.46 %
-150.7 %
-230.74 %
(Mar 31 2022)   (Mar 31 2025)







Financial Statements
Biohaven Ltd's II. Quarter Investments $ 308 Millions BHVN's Balance sheet
Biohaven Ltd's II. Quarter Income $ -137 Millions Quarterly BHVN's Income Statement
BHVN's Income by Division See BHVN's Income by Division


BHVN Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 336 461 435 572 543
Y / Y Investment Growth -27.2 % 5.83 % -23.83 % 5.29 % 318.01 %
Net Income in Millions -739 -846 -408 -570 -848
Y / Y Net Income Growth - - - - -
Annual Return On Investment -220.21 % -183.65 % -93.72 % -99.74 % -156.24 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BHVN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BHVN's Competitors
Subscribers only: Roi for Biohaven Ltd's Suppliers
Subscribers only: Return On Investment for BHVN's Customers

Other Ratios
BHVN's Roa BHVN's Inventory Turnover Ratio BHVN's Growth Rates BHVN's Dividend Statistics
BHVN's Profitability Ratios BHVN's Asset Turnover Ratio BHVN's Dividend Growth
BHVN's Roe BHVN's Valuation Ratios BHVN's Financial Strength Ratios BHVN's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-08-13T05:53:28+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.